Osteopore Secures Vietnam Hospital Contracts For Orthopaedic Implants

MT Newswires Live08-04

Osteopore (ASX:OSX) has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy (HTO) solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.

The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate (CAGR) through 2028 due to aging demographics and rising demand, the filing said.

The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.

The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2556369870?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-04 13:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556369870","market":"us","top_or_hot":-1,"title":"Osteopore Secures Vietnam Hospital Contracts For Orthopaedic Implants","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/OSX.AU\">Osteopore</a> (ASX:OSX) has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy (HTO) solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.</p><p>The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate (CAGR) through 2028 due to aging demographics and rising demand, the filing said.</p><p>The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.</p><p>The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Osteopore Secures Vietnam Hospital Contracts For Orthopaedic Implants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOsteopore Secures Vietnam Hospital Contracts For Orthopaedic Implants\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-04 13:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/OSX.AU\">Osteopore</a> (ASX:OSX) has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy (HTO) solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.</p><p>The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate (CAGR) through 2028 due to aging demographics and rising demand, the filing said.</p><p>The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.</p><p>The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4172","symbol_name":"水公用事业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2556369870","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556369870","pubTimestamp":1754284556,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Osteopore  has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy  solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate  through 2028 due to aging demographics and rising demand, the filing said.The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4172":"水公用事业","OSX.AU":"Osteopore","CAGR":"California Grapes International, Inc.","BK4159":"经销商","HTO":"H2O AMERICA","BK7126":"医疗保健用品","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC"},"translate_title":"Osteopore获得越南医院骨科植入物合同","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAGR":1,"HTO":1,"OSX.AU":0.9},"content_text":"Osteopore (ASX:OSX) has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy (HTO) solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate (CAGR) through 2028 due to aging demographics and rising demand, the filing said.The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556369870","isCrawlerRequest":true}